CXCR4 and prostate cancer: For example, miR-494-3p has been shown to inhibit CXCR4 expression after transcription processes in prostate cancer [99]; lncRNA UCA1 activates CXCR4 through inhibiting the activity of miR-204 to promote the progression of prostate cancer [100].